期刊文献+

炎症性肠病合并结直肠癌的流行病学和防治进展 被引量:12

下载PDF
导出
摘要 炎症性肠病(inflammatory bowel disease, IBD)主要由溃疡性结肠炎(ulcerative colitis,UC)和克罗恩病(Crohn’s disease,CD)组成,以腹痛、腹泻、体重减轻及发作缓解反复交替为主要临床表现。结直肠癌(colorectal cancer,CRC)是IBD患者死亡的主要原因,占IBD全因死亡率的10%~15%[1-3]。IBD患者并发CRC的风险大约是普通人群的3倍,而且随着IBD患者人群的扩大,其CRC的检出人群也在增加[4-5]。IBD相关的CRC通常是多灶性、平坦、界限不清的病变,预后较差[6]。
出处 《中国临床医生杂志》 2021年第12期1409-1413,共5页 Chinese Journal For Clinicians
基金 辽宁省高等学校基本科研项目(LFWK201707)。
  • 相关文献

参考文献6

二级参考文献75

  • 1Maria Gazouli,Ioanna Pachoula,Ioanna Panayotou,Gerassimos Mantzaris,George Chrousos,Nicholas P Anagnou,Eleftheria Roma-Giannikou.NOD2/CARD15 , ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn’s disease[J].World Journal of Gastroenterology,2010,16(14):1753-1758. 被引量:7
  • 2Wei-Xu Chen,Li-Hua Ren,Rui-Hua Shi.Implication of miRNAs for inflammatory bowel disease treatment:Systematic review[J].World Journal of Gastrointestinal Pathophysiology,2014,5(2):63-70. 被引量:31
  • 3Martin JW Meijer,Marij AC Mieremet-Ooms,Ruud A van Hogezand,Cornelis BHW Lamers,Daniel W Hommes,Hein W Verspaget.Role of matrix metalloproteinase,tissue inhibitor of metalloproteinase and tumor necrosis factor-α single nucleotide gene polymorphisms in inflammatory bowel disease[J].World Journal of Gastroenterology,2007,13(21):2960-2966. 被引量:15
  • 4David S. Kotlyar,Mark T. Osterman,Robert H. Diamond,David Porter,Wojciech C. Blonski,Mariusz Wasik,Sami Sampat,Manuel Mendizabal,Ming V. Lin,Gary R. Lichtenstein.A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease[J]. Clinical Gastroenterology and Hepatology . 2011 (1)
  • 5Christian Münz,Ann Moormann.Immune escape by Epstein–Barr virus associated malignancies[J]. Seminars in Cancer Biology . 2008 (6)
  • 6Natalie A. Molodecky,Ing Shian Soon,Doreen M. Rabi,William A. Ghali,Mollie Ferris,Greg Chernoff,Eric I. Benchimol,Remo Panaccione,Subrata Ghosh,Herman W. Barkema,Gilaad G. Kaplan.Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review[J].Gastroenterology.2012(1)
  • 7Laurent Peyrin–Biroulet,Kiarash Khosrotehrani,Fabrice Carrat,Anne–Marie Bouvier,Jean–Baptiste Chevaux,Tabassome Simon,Frank Carbonnel,Jean–Frédéric Colombel,Jean–Louis Dupas,Philippe Godeberge,Jean–Pierre Hugot,Marc Lémann,Stéphane Nahon,Jean–Marc Sabaté,Gilbert Tucat,Laurent Beaugerie.Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease[J].Gastroenterology.2011(5)
  • 8W. G.Dixon,K. D.Watson,M.Lunt,L. K.Mercer,K. L.Hyrich,D. P. M.Symmons.Influence of anti–tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register[J].Arthritis Care Res.2010(6)
  • 9Nika N Danial,Stanley J Korsmeyer.Cell Death[J].Cell.2004(2)
  • 10Millie D. Long,Christopher F. Martin,Clare A. Pipkin,Hans H. Herfarth,Robert S. Sandler,Michael D. Kappelman.Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease[J]. Gastroenterology . 2012 (2)

共引文献157

同被引文献133

引证文献12

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部